Drug Coated Balloon-Only Strategy in De Novo Lesions of Large Coronary Vessels

狼牙棒 医学 冠状动脉疾病 传统PCI 心脏病学 冠状动脉 内科学 支架 血管成形术 气球 罪魁祸首 动脉 临床终点 血运重建 经皮冠状动脉介入治疗 药物洗脱支架 靶病变 人口 病变 再狭窄 外科 心肌梗塞 临床试验 环境卫生
作者
Mark Rosenberg,Matthias Waliszewski,Florian Krackhardt,Ken Min Chin,Wan Azman Wan Ahmad,Giuseppe Caramanno,Diego Milazzo,Amin Ariff Nuruddin,Houng Bang Liew,Oteh Maskon,A Bento,Jean Christophe Macia,Norbert Frey
出处
期刊:Journal of Interventional Cardiology [Hindawi Limited]
卷期号:2019: 1-8 被引量:24
标识
DOI:10.1155/2019/6548696
摘要

Objectives . We analyzed the efficacy of drug coated balloons (DCB) as a stand-alone-therapy in de novo lesions of large coronary arteries. DCBs seem to be an attractive alternative for the stent-free interventional treatment of de novo coronary artery disease (CAD). However, data regarding a DCB-only approach in de novo CAD are currently limited to vessels of small caliber. Methods . By means of propensity score (PS) matching 234 individuals with de novo CAD were identified with similar demographic characteristics. This patient population was stratified in a 1:1 fashion according to a reference vessel diameter cut-off of 2.75 mm in small and large vessel disease. The primary endpoint was the rate of clinically driven target lesion revascularization (TLR) at 9 months. Results . Patients with small vessel disease had an average reference diameter of 2.45 ± 0.23 mm, while the large vessel group averaged 3.16 ± 0.27 mm. Regarding 9-month major adverse cardiac event (MACE), 5.7% of the patients with small and 6.1% of the patients with large vessels had MACE (p=0.903). Analysis of the individual MACE components revealed a TLR rate of 3.8% in small and 1.0% in large vessels (p=0.200). Of note, no thrombotic events in the DCB treated coronary segments occurred in either group during the 9-month follow-up. Conclusions . Our data demonstrate for the first time that DCB-only PCI of de novo lesions in large coronary arteries (>2.75 mm) is safe and as effective. Interventional treatment for CAD without permanent or temporary scaffolding, demonstrated a similar efficacy for large and small vessels.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
热爱科研的刘完成签到,获得积分10
刚刚
冯哈哈发布了新的文献求助10
1秒前
DongWei95应助chongya采纳,获得10
2秒前
爆米花应助踏实口红采纳,获得10
3秒前
4秒前
4秒前
whatever举报若也求助涉嫌违规
6秒前
机智鱼应助负责的中道采纳,获得10
7秒前
冯哈哈完成签到,获得积分10
7秒前
桐桐应助重要寒珊采纳,获得10
8秒前
小白完成签到,获得积分20
8秒前
冉亦发布了新的文献求助20
10秒前
星沉静默完成签到 ,获得积分10
10秒前
11秒前
12秒前
12秒前
丘比特应助iiLI采纳,获得10
12秒前
czlianjoy完成签到,获得积分10
14秒前
15秒前
小白发布了新的文献求助10
16秒前
16秒前
李大白完成签到 ,获得积分10
17秒前
绿麦盲区完成签到,获得积分10
19秒前
19秒前
负责的中道完成签到,获得积分20
22秒前
22秒前
666完成签到 ,获得积分10
22秒前
stories发布了新的文献求助30
22秒前
不晚完成签到,获得积分10
23秒前
whatever举报小猫最受求助涉嫌违规
24秒前
24秒前
阿大撒2发布了新的文献求助10
24秒前
25秒前
爆米花应助Cole采纳,获得10
27秒前
任ren发布了新的文献求助10
28秒前
小鹿5460完成签到,获得积分10
29秒前
番茄小超人2号完成签到 ,获得积分10
29秒前
充电宝应助fossick2010采纳,获得10
29秒前
科目三应助WQ采纳,获得10
29秒前
星河完成签到,获得积分10
29秒前
高分求助中
Sustainability in ’Tides Chemistry 1500
The ACS Guide to Scholarly Communication 1000
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
Handbook of the Mammals of the World – Volume 3: Primates 805
Ethnicities: Media, Health, and Coping 800
Historia de la ciencia jurídica europea 600
Gerard de Lairesse : an artist between stage and studio 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3069598
求助须知:如何正确求助?哪些是违规求助? 2723649
关于积分的说明 7482529
捐赠科研通 2370718
什么是DOI,文献DOI怎么找? 1257111
科研通“疑难数据库(出版商)”最低求助积分说明 609851
版权声明 596861